Patents-Review.com
ClassID:

243703 ⎘

Y10S977/915 - CPC Classification

Classification description:

Nanotechnology; Specified use of nanostructure for medical, immunological, body treatment, or diagnosis Therapeutic or pharmaceutical composition

Sub-classes:
Recent Application in this class:
#1
20230090162
2023-03-23

ENGINEERED METAL NANOPARTICLES AND METHODS THEREOF

 #2
20210000868
2021-01-07

ENGINEERED METAL NANOPARTICLES AND METHODS THEREOF

 #3
20200399398
2020-12-24

TUBULAR NANOSTRUCTURE TARGETED TO CELL MEMBRANE

 #4
20200306717
2020-10-01

Plasmonic assisted systems and methods for interior energy-activation from an exterior source

 #5
20190134596
2019-05-09

Plasmonic assisted systems and methods for interior energy-activation from an exterior source

 #6
20190134595
2019-05-09

Plasmonic assisted systems and methods for interior energy-activation from an exterior source

 #7
20190117674
2019-04-25

Method of treatment using nanoparticulate ganaxolone formulations

 #8
20190117673
2019-04-25

GANAXOLONE FORMULATION AND USE THEREOF

 #9
20190023584
2019-01-24

Iron oxide nanoparticles doped with alkali metals or alkali earth metals capable of gigantic AC magnetic self-heating in biocompatible AC magnetic field and method of preparing the same

 #10
20180304225
2018-10-25

Systems and methods for interior energy-activation from an exterior source

 #11
20180271904
2018-09-27

Engineered metal nanoparticles and methods thereof

 #12
20180117008
2018-05-03

Formulation of indomethacin

 #13
20170304447
2017-10-26

Nanotube trans-membrane channels mimicking biological porins

 #14
20170239637
2017-08-24

Systems and methods for interior energy-activation from an exterior source

 #15
20170173350
2017-06-22

Plasmonic assisted systems and methods for interior energy-activation from an exterior source

 #16
20170173177
2017-06-22

Tubular nanostructure targeted to cell membrane

 #17
20170128591
2017-05-11

Peptide Containing Porphyrin Lipid Nanovesicles

 #18
20170121472
2017-05-04

Plasmonic assisted systems and methods for interior energy-activation from an exterior source

 #19
20170095448
2017-04-06

Formulation of indomethacin

 #20
20170081195
2017-03-23

Functionalized graphene

 #21
20170045524
2017-02-16

Passivated nanoparticles

 #22
20160367481
2016-12-22

Cancer cell targeting using nanoparticles

 #23
20160175254
2016-06-23

THE SYNTHESIS OF CORE-SHELL METAL-SEMICONDUCTOR NANOMATERIALS

 #24
20160175243
2016-06-23

NANOROD MATERIALS AND METHODS OF MAKING AND USING SAME

 #25
20160022637
2016-01-28

Formulation of indomethacin

 #26
20150313843
2015-11-05

Solid ganaxolone compositions and methods for the making and use thereof

 #27
20150218001
2015-08-06

PREPARATION METHOD OF HETEROATOM DOPED MULTIFUNCTIONAL CARBON QUANTUM DOT AND APPLICATION THEREOF

 #28
20150190508
2015-07-09

Devices for thermally induced transformations controlled by irradiation of functionalized fullerenes

 #29
20150157737
2015-06-11

Polymers for functional particles

 #30
20150148870
2015-05-28

Noble metal nanoparticles, method for preparing the same and their application

 #31
20140356271
2014-12-04

METHODS AND MATERIALS FOR MAKING CERIUM NANOPARTICLES

 #32
20140256781
2014-09-11

Formulation of indomethacin

 #33
20140255494
2014-09-11

Formulation of indomethacin

 #34
20140235706
2014-08-21

Cancer cell targeting using nanoparticles

 #35
20140213643
2014-07-31

Long-acting nanoencapsulated coumarin arthropod repellent formulations and methods of use thereof

 #36
20140194487
2014-07-10

Formulation of indomethacin

 #37
20140154309
2014-06-05

Solid ganaxolone compositions and methods for the making and use thereof

 #38
20140151912
2014-06-05

Virus/nanowire encapsulation within polymer microgels for 2D and 3D devices for energy and electronics

 #39
20140065718
2014-03-06

Hydrogen peroxide sensitive metal nanoparticles, method for producing the same and hydrogen peroxide detection system comprising the same

 #40
20130337070
2013-12-19

Coated Nanoparticle Therapy for Skin Cancer

 #41
20130130348
2013-05-23

Polymers for functional particles

 #42
20130122063
2013-05-16

Nanotubes as mitochondrial uncouplers

 #43
20130102591
2013-04-25

COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF PULMONARY HYPERTENSION

 #44
20130095184
2013-04-18

Metal-containing materials for treatment of bacterial conditions

 #45
20130079382
2013-03-28

Methods and Compositions for Modulating Gene Expression Using Oligonucleotide Based Drugs Administered in vivo or in vitro

 #46
20130071472
2013-03-21

Fascile synthesis of biocompatible polymer capsule nanoparticles for drug encapsulation

 #47
20130039859
2013-02-14

Passivated nanoparticles

 #48
20130034590
2013-02-07

Delivery of hydrophilic drugs

 #49
20120263795
2012-10-18

Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters

 #50
20120213830
2012-08-23

Suspension comprising benzimidazole carbamate and a polysorbate

 #51
20120149843
2012-06-14

Nanofibers and morphology shifting micelles

 #52
20120135048
2012-05-31

NOVEL FORMULATION OF INDOMETHACIN

 #53
20120123182
2012-05-17

Devices for thermally induced transformations controlled by irradiation of functionalized fullerenes

 #54
20120121689
2012-05-17

SMALL INTERFERING RNA DELIVERY

 #55
20120052098
2012-03-01

Liquid ganaxolone formulations and methods for the making and use thereof

 #56
20120004293
2012-01-05

Cancer cell targeting using nanoparticles

 #57
20110256183
2011-10-20

Hydrogels with network defects enhanced by nanoparticle incorporation

 #58
20110236487
2011-09-29

Solid ganaxolone formulations and methods for the making and use thereof

 #59
20110229532
2011-09-22

Process for nanoemulsification of curcumin and derivatives of curcumin

 #60
20110224288
2011-09-15

Cancer cell targeting using nanoparticles

 #61
20110195095
2011-08-11

INJECTABLE NANOPARTICULATE OLANZAPINE FORMULATIONS

 #62
20110177154
2011-07-21

Tubular nanostructure targeted to cell membrane

 #63
20110171128
2011-07-14

Aprotinin polypeptides for transporting a compound across the blood-brain barrier

 #64
20110160694
2011-06-30

Nanotubes as mitochondrial uncouplers

 #65
20110159056
2011-06-30

Methods and materials for stimulating proliferation of stem cells

 #66
20110142938
2011-06-16

Nanotubes as mitochondrial uncouplers

 #67
20110118825
2011-05-19

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

 #68
20110116993
2011-05-19

Virus/nanowire encapsulation within polymer microgels for 2D and 3D devices for energy and electronics

 #69
20110091510
2011-04-21

NANOROD MATERIALS AND METHODS OF MAKING AND USING SAME

 #70
20110071612
2011-03-24

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

 #71
20110066251
2011-03-17

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

 #72
20100323199
2010-12-23

Polymers for functional particles

 #73
20100292314
2010-11-18

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

 #74
20100240742
2010-09-23

Anti-angiogenic nanoparticle compositions

 #75
20100233781
2010-09-16

Tubular nanostructure targeted to cell membrane

 #76
20100222281
2010-09-02

Delivery of hydrophilic drugs

 #77
20100120692
2010-05-13

Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration

 #78
20100120691
2010-05-13

Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration

 #79
20100069606
2010-03-18

Tubular nanostructure targeted to cell membrane

 #80
20100068808
2010-03-18

Tubular nanostructure targeted to cell membrane

 #81
20100021533
2010-01-28

Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance

 #82
20090294692
2009-12-03

Plasmonic assisted systems and methods for interior energy-activation from an exterior source

 #83
20090221793
2009-09-03

Process for preparing a pentopyranosyl nucleic acid conjugate

 #84
20090169621
2009-07-02

Pharmaceutical excipient having improved compressibility

 #85
20090156500
2009-06-18

Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration

 #86
20090149386
2009-06-11

NEUREGULINS FOR PREVENTION AND TREATMENT OF DAMAGE FROM ACUTE ASSAULT ON VASCULAR AND NEURONAL TISSUE AND AS REGULATORS OF NEURONAL STEM CELL MIGRATION

 #87
20090149385
2009-06-11

Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration

 #88
20090076171
2009-03-19

Metallofullerols and their applications for preparation of medicine for inhibition of tumor growth

 #89
20090074830
2009-03-19

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

 #90
20090074748
2009-03-19

Immunological control of beta-amyloid levels in vivo

 #91
20090061010
2009-03-05

Cancer cell targeting using nanoparticles

 #92
20090036517
2009-02-05

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

 #93
20080318275
2008-12-25

Hepatitis C virus asialoglycoproteins

 #94
20080299039
2008-12-04

Aprotinin polypeptides for transporting a compound across the blood-brain barrier

 #95
20080220089
2008-09-11

Medical agent for preventing or treating diseases resulting from one of inflammation and remodeling, and method for preventing or treating the diseases

 #96
20080166412
2008-07-10

METHODS AND MATERIALS FOR STIMULATING PROLIFERATION OF STEM CELL

 #97
20080166387
2008-07-10

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

 #98
20080146518
2008-06-19

Cationic lipids for the transfection of nucleic acids

 #99
20080081074
2008-04-03

Polymers for functional particles

 #100
20080020063
2008-01-24

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

 #101
20070298123
2007-12-27

ANTI-ANGIOGENIC COMPOSITIONS AND METHODS OF USE

 #102
20070243136
2007-10-18

Methods and compositions for imaging

 #103
20070237831
2007-10-11

Nanoparticles for monoclonal antibody delivery

 #104
20070155665
2007-07-05

Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration

 #105
20070148252
2007-06-28

Solid ganaxolone formulations and methods for the making and use thereof

 #106
20070141161
2007-06-21

Liquid ganaxolone formulations and methods for the making and use thereof

 #107
20070077209
2007-04-05

Methods of treating mammals with stabilized particle dispersions containing excipient surface-modified nanoparticles

 #108
20070020310
2007-01-25

Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers

 #109
20070003630
2007-01-04

Anti-angiogenic compositions and methods of use

 #110
20070003629
2007-01-04

Anti-angiogenic compositions and methods of use

 #111
20060286175
2006-12-21

Stabilized dispersions comprising excipient surface-modified organic nanoparticles and medicament particles

 #112
20060275281
2006-12-07

Nanotubes as mitochondrial uncouplers

 #113
20060270840
2006-11-30

Pentopyranosyl nucleic acid conjugates

 #114
20060240113
2006-10-26

Anti-angiogenic compositions and methods of use

 #115
20060228371
2006-10-12

Immunological control of beta-amyloid levels in vivo

 #116
20060189578
2006-08-24

Method for the synthesis of compounds of formula I and their uses thereof

 #117
20060189515
2006-08-24

Molecules for transporting a compound across the blood-brain barrier

 #118
20060154918
2006-07-13

Injectable nanoparticulate olanzapine formulations

 #119
20060148760
2006-07-06

Method for the sysnthesis of compounds of formula I and their uses thereof

 #120
20060127445
2006-06-15

Anti-angiogenic compositions and methods of use

 #121
20060121117
2006-06-08

Anti-angiogenic compositions and methods of use

 #122
20060120964
2006-06-08

Magnetic nanoparticles comprising Gadolinium and method of fabrication

 #123
20060099148
2006-05-11

Methods and compositions for imaging

 #124
20060035854
2006-02-16

Compositions and methods for coating medical devices

 #125
20050277641
2005-12-15

2,4-disubstituted triazine derivatives

 #126
20050208137
2005-09-22

Anti-angiogenic compositions and methods of use

 #127
20050147613
2005-07-07

Immunological control of β-amyloid levels in vivo

 #128
20050142189
2005-06-30

Emulsion vehicle for poorly soluble drugs

 #129
20050123605
2005-06-09

Anti-angiogenic compositions and methods of use

 #130
20050089843
2005-04-28

Antibodies to hepatitis C virus asialoglycoproteins

 #131
20050053945
2005-03-10

Process for the preparation of a pentopyranosyl conjugate

 #132
20050049223
2005-03-03

Basic drug compositions with enhanced bioavailability

 #133
20050013861
2005-01-20

Pharmaceutical excipient having improved compressibility

 #134
16734152
2020-11-10

Method of preparing biogenic silver nanoparticles

 #135
15334695
2017-09-05

One-step synthesis of graphene quantum dots

 #136
15096235
2018-04-03

Antibacterial activity of silver-graphene quantum dots nanocomposites against gram-positive and gram-negative bacteria

 #137
13490891
2015-02-10

Methods of promoting angiogenesis using cerium oxide nanoparticles